A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Hummingbird Bioscience
Hummingbird Bioscience
Maia Biotechnology
AVEO Pharmaceuticals, Inc.
KaliVir Immunotherapeutics
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Merck Sharp & Dohme LLC
Eli Lilly and Company